Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions

Proceedings of the National Academy of Sciences of the United States of America
Cheol-Hee ShinSung-Gil Chi

Abstract

XIAP-associated factor 1 (XAF1) is a tumor suppressor that is commonly inactivated in multiple human neoplasms. However, the molecular mechanism underlying its proapoptotic function remains largely undefined. Here, we report that XAF1 induction by heavy metals triggers an apoptotic switch of stress response by destabilizing metallothionein 2A (MT2A). XAF1 directly interacts with MT2A and facilitates its lysosomal degradation, resulting in the elevation of the free intercellular zinc level and subsequent activation of p53 and inactivation of XIAP. Intriguingly, XAF1 is activated as a unique transcription target of metal-regulatory transcription factor-1 (MTF-1) in signaling apoptosis, and its protein is destabilized via the lysosomal pathway by MTF-1-induced MT2A under cytostatic stress conditions, indicating the presence of mutual antagonism between XAF1 and MT2A. The antagonistic interplay between XAF1 and MT2A acts as a key molecular switch in MTF-1-mediated cell-fate decisions and also plays an important role in cell response to various apoptotic and survival factors. Wild-type (WT) XAF1 but not MT2A binding-deficient mutant XAF1 increases the free intracellular zinc level and accelerates WT folding of p53 and degradation of...Continue Reading

References

Feb 15, 2001·Nature Cell Biology·P ListonR G Korneluk
Dec 4, 2003·Mutation Research·M George CherianBoon-Huat Bay
Jul 29, 2004·Histopathology·S E TheocharisG P Kouraklis
Dec 22, 2004·The Journal of Investigative Dermatology·Kin Cheung P NgGang Li
Jan 25, 2006·Molecular and Cellular Biochemistry·Yan XiaAndrew C Phillips
Jul 7, 2007·The Journal of Biological Chemistry·Vinay AroraRobert G Korneluk
Nov 11, 2008·Experimental Cell Research·Rosa PucaGabriella D'Orazi
May 20, 2009·Cell·Jan-Philipp Kruse, Wei Gu
Jan 21, 2010·Cancer Biology & Therapy·Yihui ShiBrian J Murphy
Apr 1, 2010·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Heather M McGeeRoger S Chung
Oct 12, 2012·Clinical and Experimental Medicine·Anna KrześlakMagdalena Bryś
Mar 8, 2013·Toxicology and Applied Pharmacology·Anna KrześlakMagdalena Bryś
Oct 15, 2014·Proceedings of the National Academy of Sciences of the United States of America·Min-Goo LeeSung-Gil Chi
Feb 3, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Yaser Khaje BishakAlireza Nourazarian
Mar 12, 2015·Molecular Medicine Reports·Shinichiro Takahashi
Dec 19, 2015·Nature Reviews. Cancer·Wynand P RoosBernd Kaina
Mar 10, 2016·International Journal of Molecular Sciences·Tomoki Kimura, Taiho Kambe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.